NCT04111445View on ClinicalTrials.gov

Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

August 29, 2019

Primary Completion Date

April 27, 2021

Study Completion Date

April 27, 2021

Conditions

Solid Tumor

Interventions

DRUG

ADG116

IV infusion at Day 1 of each cycle

Trial Locations (1)

78229

NEXT Oncology, San Antonio

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Adagene Inc

INDUSTRY

NCT04111445 - Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter